Top Markets
Coin of the day
Synovics Pharmaceuticals, Inc. Synovics Pharmaceuticals, Inc.

Synovics Pharmaceuticals, Inc.

SYVC
Classement en actions #42246
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the... Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$2.98K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Synovics Pharmaceuticals, Inc. (SYVC)

Catégorie

EPS pour Synovics Pharmaceuticals, Inc. (SYVC)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Synovics Pharmaceuticals, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Synovics Pharmaceuticals, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR